Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Dimension Therapeutics, Inc. (DMTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/17/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
11/14/2017 EFFECT Form EFFECT - Notice of Effectiveness:
11/09/2017 4 FMR LLC (See Remark 1) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Unknown transaction of 3,838,249 shares @ $6, valued at $23M
Unknown transaction of 1,050,016 shares @ $6, valued at $6.3M
Unknown transaction of 5,057 shares @ $6, valued at $30.3k
11/07/2017 4 Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 278,035 shares @ $0
Disposed/sold 50,000 options to buy @ $7.14, valued at $357k
Disposed/sold 60,000 options to buy @ $1.9, valued at $114k
11/07/2017 4 Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 27,711 options to buy @ $3.57, valued at $98.9k
Disposed/sold 180,815 options to buy @ $3.57, valued at $645.5k
Disposed/sold 17,104 options to buy @ $4.09, valued at $70k
Disposed/sold 65,000 options to buy @ $7.14, valued at $464.1k
Disposed/sold 60,000 options to buy @ $1.9, valued at $114k
11/07/2017 4 Morris Arlene (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 55,772 options to buy @ $4.09, valued at $228.1k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 481,696 options to buy @ $0.56, valued at $269.7k
Disposed/sold 74,375 options to buy @ $3.57, valued at $265.5k
Disposed/sold 342,113 options to buy @ $4.09, valued at $1.4M
Disposed/sold 160,000 options to buy @ $7.14, valued at $1.1M
Disposed/sold 192,000 options to buy @ $1.9, valued at $364.8k
Disposed/sold 150,000 options to buy @ $1.35, valued at $202.5k
11/07/2017 4 Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 38,000 options to buy @ $4.6, valued at $174.8k
11/07/2017 4 GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 128,292 options to buy @ $0.56, valued at $71.8k
Disposed/sold 80,396 options to buy @ $4.09, valued at $328.8k
Disposed/sold 50,000 options to buy @ $7.14, valued at $357k
Disposed/sold 50,000 options to buy @ $1.9, valued at $95k
11/07/2017 4 Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
11/07/2017 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Dimension Therapeutics, Inc",
"Amended and Restated Bylaws of Dimension Therapeutics, Inc",
"Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics"
11/07/2017 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/07/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/07/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/07/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/07/2017 GN Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics
11/06/2017 10-Q Quarterly Report for the period ended September 30, 2017
10/31/2017 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Dimension Therapeutics, Inc.
10/26/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/26/2017 GN Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx's Acquisition of Dimension
10/23/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/17/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/12/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/11/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/10/2017 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/10/2017 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/03/2017 425 Form 425 - Prospectuses and communications, business combinations:
10/03/2017 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy